Sign up
All neurology trends
SteadyNeurology · updated 18 Oct 2026

Tenecteplase in stroke

Tenecteplase as the thrombolytic for acute ischaemic stroke.

Key point

Intravenous tenecteplase before thrombectomy showed benefit in ASPECTS <8, but no functional improvement and possible safety concerns in ASPECTS 8-10.

From: Effect of Baseline ASPECTS on Tenecteplase Efficacy Before Thrombectomy in Acute Large-Vessel Occlusion Stroke: A Post Hoc Analysis of the BRIDGE-TNK Randomized Trial (Neurology, 2026 Sep 22) ↗
51PubDaily Trend Score
+30%new papers vs last year
32new trials registered
0new guidelines this year

Papers per year

Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 11, 21, 12, 25, 32.

All papers from the last 12 months

255 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…

Open this search in PubMed
  1. Neutrophil to Lymphocyte Ratio and Neurological Outcome in Ischemic Stroke at 4.5 to 24 Hours: A Post Hoc Analysis of TRACE-III Trial
    Neurol Ther2026 Oct 16PMID 42886317
  2. Tenecteplase, alteplase, and endovascular thrombectomy in extended-window acute ischemic stroke with intracranial large-vessel occlusion: a Bayesian network meta-analysis
    J Neurol2026 Oct 16PMID 42886241Review
  3. Intra-arterial thrombolytics after endovascular thrombectomy for acute ischemic stroke: A network meta-analysis of RCTs
    J Neurol Sci2026 Oct 15PMID 42480380Systematic review
  4. Balancing Ischemia and Hemorrhage After Tenecteplase in Wake-Up Stroke
    JACC Case Rep2026 Oct 14PMID 42559778
  5. Thrombolysis in the Delayed Treatment Window for Acute Ischemic Stroke: Updated Systematic Review and Meta-Analysis
    Stroke2026 Oct 13PMID 42866880
  6. Stroke thrombectomy of a mural thrombus in a severe dolichoectatic basilar artery with double parallel large stent retrievers and Sofia 88
    J Neurointerv Surg2026 Oct 13PMID 40473383
  7. Clinical outcomes after intravenous thrombolysis for acute ischemic stroke in low- and middle-income countries: a pooled analysis of 67,917 patients and systematic review
    Neurol Res2026 Oct 11PMID 42860667Review
  8. Effectiveness and safety of tenecteplase for acute ischaemic stroke at primary stroke centres: a multicentre retrospective study
    Stroke Vasc Neurol2026 Oct 7PMID 42849921
  9. Comparative Effectiveness of Intravenous Tenecteplase versus Alteplase in Posterior Circulation Ischemic Stroke: A Systematic Review and Meta-Analysis
    Brain Behav2026 OctPMID 42851038Meta-analysisSystematic reviewReview
  10. Door-to-Needle Optimization in Acute Ischemic Stroke: A Review of Rapid Emergency Department Interventions
    Cardiol Cardiovasc Med2026 OctPMID 42807530

More neurology trends

All specialties →

Focused ultrasound for tremor

Rising
+32%new papersScore 72
20212026

MR-guided focused ultrasound for essential tremor and Parkinson's disease.

Key point: MRgFUS thalamotomy is safe, effective, and durable for refractory essential tremor; it appears safe and effective for Parkinson disease tremor, with uncertain durability.

184 papers / yr12 new trials2 new guidelines
See all papers →

Auricular vagus nerve stimulation

Rising
+45%new papersScore 72
20212026

Studies of transcutaneous auricular vagus nerve stimulation (taVNS), a non-invasive neuromodulation technique.

326 papers / yr144 new trials
See all papers →

CGRP-targeted migraine treatment

Rising
+17%new papersScore 55
20212026

Gepants and anti-CGRP antibodies for migraine.

612 papers / yr32 new trials5 new guidelines
See all papers →

Post-stroke dysphagia

Steady
+23%new papersScore 46
20212026

Studies of swallowing disorders after stroke and their treatment, including neuromodulation.

226 papers / yr23 new trials1 new guideline
See all papers →

Anti-amyloid antibodies

Steady
+27%new papersScore 43
20212026

Lecanemab, donanemab and related antibodies for early Alzheimer's disease.

405 papers / yr12 new trials
See all papers →

New myasthenia gravis therapies

Steady
+17%new papersScore 43
20212026

FcRn blockers and complement inhibitors in myasthenia gravis.

Key point: Terminal complement pathway inhibitors and neonatal Fc receptor antagonists are reshaping myasthenia gravis treatment, with robust evidence of efficacy and safety.

246 papers / yr19 new trials1 new guideline
See all papers →

Too many papers to read?

PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.

Get started
How these numbers are counted

PubMed query, searched in titles and abstracts by publication date:

tenecteplase[tiab] AND stroke[tiab]

Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.